COMMONWEALTH EQUITY SERVICES, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$427
-10.5%
27,596
-9.1%
0.00%0.0%
Q2 2023$477
-16.2%
30,356
-12.2%
0.00%0.0%
Q1 2023$569
+4.0%
34,576
-1.5%
0.00%0.0%
Q4 2022$547
-99.9%
35,106
-46.7%
0.00%
-50.0%
Q3 2022$854,000
-10.5%
65,857
-3.1%
0.00%0.0%
Q2 2022$954,000
-12.4%
67,990
-10.6%
0.00%0.0%
Q1 2022$1,089,000
+0.9%
76,071
-3.9%
0.00%0.0%
Q4 2021$1,079,000
-45.6%
79,174
-34.6%
0.00%
-60.0%
Q3 2021$1,983,000
-30.7%
121,067
-28.8%
0.01%
-28.6%
Q2 2021$2,862,000
+12.9%
170,096
+22.5%
0.01%0.0%
Q1 2021$2,534,000
+43.4%
138,807
+42.9%
0.01%
+40.0%
Q4 2020$1,767,000
+265.8%
97,133
+258.5%
0.01%
+150.0%
Q3 2020$483,000
-10.9%
27,094
-10.4%
0.00%0.0%
Q2 2020$542,000
+12.7%
30,246
-4.7%
0.00%0.0%
Q1 2020$481,000
-31.7%
31,736
-11.1%
0.00%
-33.3%
Q4 2019$704,000
+20.8%
35,695
+5.2%
0.00%
+50.0%
Q3 2019$583,000
+28.7%
33,928
+32.5%
0.00%0.0%
Q2 2019$453,000
-37.4%
25,600
-28.0%
0.00%
-33.3%
Q1 2019$724,00035,5670.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders